ABL Bio Inc. (298380.KQ)
KRW 27400.0
(-5.03%)
KRW 27400.0
(-5.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.36 Billion | 72.13 Billion | -40.6 Billion | -47.29 Billion | -23.85 Billion | -12.66 Billion |
| Net Income | -2.64 Billion | 3.2 Billion | -43.55 Billion | -55.6 Billion | -37 Billion | -117.23 Billion |
| Depreciation & Amortization | 2.6 Billion | 2.32 Billion | 2.16 Billion | 2.06 Billion | 1.67 Billion | 629.58 Million |
| Deferred income taxes | -6.05 Billion | -5.7 Billion | -5.4 Billion | - | - | - |
| Stock-based compensation | 6 Billion | 4.38 Billion | 7.52 Billion | 12.94 Billion | - | - |
| Change in working capital | -32.97 Billion | 60.31 Billion | 631.38 Million | -3.84 Billion | 1.07 Billion | 3.9 Billion |
| Other non-cash items | 9.99 Billion | 10.78 Billion | 3.02 Billion | 15.98 Billion | 8.6 Billion | 106.45 Billion |
| Investing Cash Flow | 29.88 Billion | -71.24 Billion | 20.22 Billion | -3.62 Billion | -8.25 Billion | -22.77 Billion |
| Investments in PPE | -5.84 Billion | -3.63 Billion | -1.26 Billion | -630.93 Million | -3.83 Billion | -1.31 Billion |
| Acquisitions | 7.46 Million | -21.09 Billion | 12 Million | 1.5 Million | 2.87 Million | 7.72 Million |
| Investment purchases | -112.56 Billion | -78.84 Billion | -66.55 Billion | -67.34 Billion | -44.68 Billion | -36.26 Billion |
| Sales/Maturities of investments | 127.85 Billion | 32.61 Billion | 88.01 Billion | 64.47 Billion | 40.47 Billion | 14.9 Billion |
| Other Investing Activities | 20.43 Billion | -282.81 Million | 17.61 Million | -127.8 Million | -208.89 Million | -101.24 Million |
| Financing Cash Flow | 1.43 Billion | 4.64 Billion | 284.12 Million | 598.29 Million | -47.48 Million | 155.6 Billion |
| Debt repayment | -3 Billion | -1.09 Billion | -959.45 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.71 Billion | 5.74 Billion | 1.24 Billion | 1.48 Billion | 643.05 Million | 155.6 Billion |
| Other Financing Activities | -1.97 Billion | -11.67 Million | -12.36 Million | -12.81 Million | -690.54 Million | - |
| Accounts receivables | -511.28 Million | -458.43 Million | 1.46 Billion | -1.76 Billion | 5.14 Billion | -5.64 Billion |
| Accounts payables | 370.31 Million | 604.68 Million | - | - | - | 476.43 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -32.83 Billion | 60.17 Billion | -829.8 Million | -2.07 Billion | -4.07 Billion | 9.07 Billion |
| Cash at beginning of period | 25.13 Billion | 21.58 Billion | 40.65 Billion | 91.14 Billion | 122.03 Billion | 1.99 Billion |
| Cash at end of period | 28.06 Billion | 25.13 Billion | 21.58 Billion | 40.65 Billion | 91.14 Billion | 122.03 Billion |
| Capital Expenditure | -5.84 Billion | -3.63 Billion | -1.26 Billion | -630.93 Million | -3.83 Billion | -1.31 Billion |
| Effect of forex changes on cash | -29.86 Million | -1.98 Billion | 1.02 Billion | -164.89 Million | 1.27 Billion | - |
| Net cash flow / Change in cash | 2.92 Billion | 3.54 Billion | -19.06 Billion | -50.48 Billion | -30.88 Billion | 120.03 Billion |
| Free Cash Flow | -34.2 Billion | 68.49 Billion | -41.87 Billion | -47.92 Billion | -27.69 Billion | -13.98 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.4 Billion | -11.97 Billion | -12.51 Billion | -2.64 Billion | -4.1 Billion | -10.35 Billion |
| Depreciation & Amortization | 592.03 Million | 639.5 Million | 626.68 Million | 2.6 Billion | 664.03 Million | 651.95 Million |
| Deferred income taxes | - | - | -1.65 Billion | -6.05 Billion | -2.56 Billion | -401.84 Million |
| Stock-based compensation | -433.64 Million | 1.55 Billion | 1.59 Billion | 6 Billion | 1.32 Billion | 1.43 Billion |
| Change in working capital | -9.41 Billion | -6.1 Billion | -9.26 Billion | -32.97 Billion | -8.79 Billion | -6.68 Billion |
| Other non-cash items | 3.34 Billion | 485.37 Million | 5.3 Billion | 9.99 Billion | 3.12 Billion | 2.55 Billion |
| Investing Cash Flow | 5.09 Billion | 3.23 Billion | 17.63 Billion | 29.88 Billion | 24.41 Billion | -955.21 Million |
| Investments in PPE | -2.1 Billion | -1.62 Billion | -4.76 Billion | -5.84 Billion | -155.43 Million | -679.46 Million |
| Acquisitions | - | 454.54 Thousand | - | 7.46 Million | 2.45 Million | - |
| Investment purchases | -36.39 Billion | -34.35 Billion | -27.45 Billion | -112.56 Billion | -30.99 Billion | -30.28 Billion |
| Sales/Maturities of investments | 43.58 Billion | 39.18 Billion | 29.39 Billion | 127.85 Billion | 55.55 Billion | 30.03 Billion |
| Other Investing Activities | 3.22 Million | 24.97 Million | 20.45 Billion | 20.43 Billion | -42.5 Thousand | -25.88 Million |
| Financing Cash Flow | 775.66 Million | -322.69 Million | 2.5 Billion | 1.43 Billion | -1.49 Billion | 315.93 Million |
| Debt repayment | -319.05 Million | -322.69 Million | -3 Billion | -3 Billion | -337.73 Million | -316.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.09 Billion | - | - | 1.71 Billion | 639.55 Million | 632.27 Million |
| Other Financing Activities | -319.05 Million | - | -177.23 Million | -1.97 Billion | -1.8 Billion | -1.35 Million |
| Accounts receivables | 512.63 Million | 405.4 Million | -789.95 Million | -511.28 Million | -96.72 Million | -79.96 Million |
| Accounts payables | -811.88 Million | 308.67 Million | 545.38 Million | 370.31 Million | -1.12 Billion | 1.19 Billion |
| Inventory | - | - | - | - | - | - |
| Other working capital | -9.11 Billion | -6.82 Billion | -9.01 Billion | -32.83 Billion | -7.56 Billion | -7.8 Billion |
| Cash at beginning of period | 13.85 Billion | 28.06 Billion | 27.47 Billion | 25.13 Billion | 15.93 Billion | 31.24 Billion |
| Cash at end of period | 996.8 Million | 13.85 Billion | 28.06 Billion | 28.06 Billion | 27.47 Billion | 15.93 Billion |
| Capital Expenditure | -2.1 Billion | -1.62 Billion | -4.76 Billion | -5.84 Billion | -155.43 Million | -679.46 Million |
| Effect of forex changes on cash | -361.28 Million | 396 Million | -2.19 Billion | -29.86 Million | 287.66 Million | -647.75 Million |
| Net cash flow / Change in cash | -12.85 Billion | -14.21 Billion | 593.35 Million | 2.92 Billion | 11.53 Billion | -15.31 Billion |
| Free Cash Flow | -20.47 Billion | -19.14 Billion | -22.1 Billion | -34.2 Billion | -11.82 Billion | -14.7 Billion |
BPCGF
KPIGREEN
1938
GNHRF
000719
TOAGF